Biomarin Pharmaceutical Inc (BMRN) — Not yet assessed · Company page | HillSignal
Verified IDBMRN · Nasdaq
Biomarin Pharmaceutical Inc
Pharmaceutical Preparations.
Company page · Records as of 18 Nov 2026
Revenue
$3.7B
12 months to Sep 2026
Money
Revenue and federal contracts, by year
Contracts obligated, federal fiscal yearCompany revenue, its fiscal year ending that year (10-K)
FY2026$0$3.2B
FY2025$0$2.9B
FY2024$0$2.4B
FY2023$0$2.1B
FY2022$0$1.8B
Committed contract money is not revenue: a multi-year contract can be funded in one year. Prime contracts only; subcontracts and classified work are not included.
Influence
Lobbying
Filings
30
Latest year
2026
Issues
Budget/Appropriations
Copyright/Patent/Trademark
Health Issues
Medical/Disease Research/Clinical Labs
Medicare/Medicaid
Pharmacy
Tariff (miscellaneous tariff bills)
Taxation/Internal Revenue Code
Political giving
Biomarin Pharmaceutical Inc. Political Action Committee Aka Biomarin Pac
Debbie Dingell (MI)$10K
Doris O. Matsui (CA)$10K
Nanette Barragan (CA)$8K
Linda T. Sanchez (CA)$8K
Kurt Schrader (OR)$5K
Lobbyists who held government posts
Joel D. BaileyCOS Rep. PanettaLD Rep. Ashford+4 more postsCOS Rep. Panetta
People
Key people
Robert M. PlengeDirector
George Eric DavisEVP, Chief Legal Officer
Robert J. HombachDirector
Willard H. DereDirector
Barbara W. BodemDirector
Timothy P. WalbertDirector
Athena CountouriotisDirector
Ian T. ClarkDirector
Maykin HoDirector
Elizabeth M. AndersonDirector
Mark J. EnyedyDirector
Cristin HubbardEVP, Chief Commercial Officer
Gregory R. FribergEVP, Chief R&D Officer
Charles Greg GuyerEVP, Chief Technical Officer
Alexander HardyChief Executive Officer
Connections
Shared personKYNTRA BIO, INC. ($KYNB)Ho Maykin is Director at one entity and Director at the other
$177KGregory R. Friberg, EVP, Chief R&D Officer: sold7 May 2026 · Source
Sources
Where the records come from
Federal contracts
USAspending award records (fiscal 2025 onward), linked by contractor ID
Purchase notices
SAM.gov
Lobbying
Senate Lobbying Disclosure Act filings
Political giving
Federal Election Commission (FEC)
Insider trades
SEC Form 4
Revenue
SEC filings (10-K, 10-Q)
Private raises
SEC Form D
Patents
USPTO, a sample of recent grants in strategic technology areas
Congressional trades
House and Senate financial disclosures
Every record on this page links to its source.
Committed contract money is not revenue.
Records as of 18 Nov 2026; revenue for the 12 months to Sep 2026.
Ask Intel
Source-backed
LD Rep. Ashford
LD Rep. Matheson
Sr. LA Rep. Matsui
LA, Sr. LA Rep. Baron Hill
Intern Rep. Rahall
John StoneCounsel, House E&C Cmte, Oversight SubcommitteeSenior Counsel, House E&C Cmte, Health Subcommittee+1 more postCounsel, House E&C Cmte, Oversight SubcommitteeSenior Counsel, House E&C Cmte, Health SubcommitteeIntern, House E&C
Daniel FarmerIntern, Staff Asst, Leg. Corr./Leg. Asst. for Rep. Debbie Wasserman SchultzLeg. Asst., Sr. Leg. Asst., Leg. Dir. for Zack Space
Remy Leigh Brim MasonSenior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty MurraySenior Health Policy Advisor Sen. Elizabeth Warren+1 more postSenior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty MurraySenior Health Policy Advisor Sen. Elizabeth WarrenIntern to Rep. Allyson Schwartz
Brent Alan Del MonteLeg. Dir. Rep. BlileySen. Counsel House Energy & Commerce Committee
Daniel MayneSENIOR REGULATORY HEALTH CONSULTANT- FOOD & DRUG ADMINISTRATION (6/2020-2/2022)REGULATORY POLICY ANALYST- FOOD & DRUG ADMINISTRATION (9/2023-6/2024)
James WilliamsSpecial Assist. to the Pres., WH Domestic Policy Council, 2019-2021Economist, WH Council of Economic Advisors, 2017-2019
Robb WaltonSenior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; R…Intern to Rep. NunesFull textSenior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Research Asst., Staff Asst., Intern on Senate HELP, Ranking Member, Sen. EnziIntern to Rep. Nunes
Alanna TemmeLegislative Director, U.S. Rep. Jon Porter
Joshua David OdintzTax Counsel, Senate Finance Committee
HOMBACH ROBERT J is Director at one entity and Director at the other
Shared personEmbecta Corp. ($EMBC)HOMBACH ROBERT J is Director at one entity and Director at the other